US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.370
  • -0.080-5.52%
Close Jun 18 16:00 ET
  • 1.380
  • +0.010+0.73%
Post 19:58 ET
40.85MMarket Cap-861P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
-73.30%-4M
-198.43%-4M
Net income from continuing operations
-8.49%-7.43M
-38.92%-39.26M
19.24%-9.72M
-198.44%-10.49M
-128.32%-12.19M
6.97%-6.85M
-231.63%-28.26M
-226.75%-12.04M
-54.23%-3.52M
-232.05%-5.34M
Operating gains losses
-4,000.10%-456.18K
22.86%239.22K
-114.46%-66.76K
---139.08K
356.25%456.18K
87.50%-11.13K
112.24%194.71K
266.00%461.74K
--0
5.88%-178.02K
Depreciation and amortization
--0
----
----
----
----
--0
----
----
----
----
Change In working capital
-268.83%-4.21M
-18.43%7.28M
-92.33%524.12K
877.66%4.1M
157.13%3.8M
-199.35%-1.14M
1,371.68%8.93M
16,759.26%6.83M
-469.82%-527.27K
236.05%1.48M
-Change in prepaid assets
4.19%-1.19M
-94.60%70.89K
-65.58%81.81K
-33.18%275.7K
73.18%955.53K
-1,227.05%-1.24M
176.55%1.31M
116.83%237.65K
24.43%412.62K
45.84%551.76K
-Change in payables and accrued expense
-3,054.68%-3.02M
-5.31%7.21M
-93.29%442.31K
506.93%3.82M
207.15%2.84M
-90.16%102.04K
652.64%7.62M
380.91%6.59M
-397.19%-939.89K
1,408.05%925.92K
Cash from discontinued investing activities
Operating cash flow
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
-73.30%-4M
-198.43%-4M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-51.68%332K
325.69%33.17M
146,813.77%27.27M
0
5.21M
981,461.43%687.09K
-75.34%7.79M
-81.15%18.56K
7.77M
0
Net issuance payments of debt
-50.26%332K
--0
---222.5K
--0
---445K
--667.5K
--0
--0
--0
--0
Net common stock issuance
----
253.69%27.49M
--27.49M
----
----
----
-75.32%7.77M
--0
----
----
Proceeds from stock option exercised by employees
--0
29,836.99%5.68M
--0
--0
--5.66M
27,890.00%19.59K
-80.74%18.97K
-81.15%18.56K
--333
--0
Cash from discontinued financing activities
Financing cash flow
-51.68%332K
325.69%33.17M
146,813.77%27.27M
--0
--5.21M
981,461.43%687.09K
-75.34%7.79M
-81.15%18.56K
--7.77M
--0
Net cash flow
Beginning cash position
26.18%23.37M
-37.62%18.52M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
238.89%29.69M
-30.75%23.19M
-45.76%19.42M
314.96%23.42M
Current changes in cash
-56.85%-11.39M
143.41%4.85M
493.73%18.4M
-263.83%-6.18M
97.40%-103.97K
-15.92%-7.26M
-153.37%-11.17M
-22.83%-4.67M
263.33%3.77M
-113.27%-4M
End cash Position
6.38%11.97M
26.18%23.37M
26.18%23.37M
-78.56%4.97M
-42.58%11.15M
-51.94%11.26M
-37.62%18.52M
-37.62%18.52M
-30.75%23.19M
-45.76%19.42M
Free cash flow
-47.47%-11.73M
-49.39%-28.32M
-89.24%-8.88M
-54.41%-6.18M
-32.89%-5.32M
-26.88%-7.95M
-77.73%-18.96M
-20.21%-4.69M
-73.30%-4M
-198.43%-4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M-73.30%-4M-198.43%-4M
Net income from continuing operations -8.49%-7.43M-38.92%-39.26M19.24%-9.72M-198.44%-10.49M-128.32%-12.19M6.97%-6.85M-231.63%-28.26M-226.75%-12.04M-54.23%-3.52M-232.05%-5.34M
Operating gains losses -4,000.10%-456.18K22.86%239.22K-114.46%-66.76K---139.08K356.25%456.18K87.50%-11.13K112.24%194.71K266.00%461.74K--05.88%-178.02K
Depreciation and amortization --0------------------0----------------
Change In working capital -268.83%-4.21M-18.43%7.28M-92.33%524.12K877.66%4.1M157.13%3.8M-199.35%-1.14M1,371.68%8.93M16,759.26%6.83M-469.82%-527.27K236.05%1.48M
-Change in prepaid assets 4.19%-1.19M-94.60%70.89K-65.58%81.81K-33.18%275.7K73.18%955.53K-1,227.05%-1.24M176.55%1.31M116.83%237.65K24.43%412.62K45.84%551.76K
-Change in payables and accrued expense -3,054.68%-3.02M-5.31%7.21M-93.29%442.31K506.93%3.82M207.15%2.84M-90.16%102.04K652.64%7.62M380.91%6.59M-397.19%-939.89K1,408.05%925.92K
Cash from discontinued investing activities
Operating cash flow -47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M-73.30%-4M-198.43%-4M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -51.68%332K325.69%33.17M146,813.77%27.27M05.21M981,461.43%687.09K-75.34%7.79M-81.15%18.56K7.77M0
Net issuance payments of debt -50.26%332K--0---222.5K--0---445K--667.5K--0--0--0--0
Net common stock issuance ----253.69%27.49M--27.49M-------------75.32%7.77M--0--------
Proceeds from stock option exercised by employees --029,836.99%5.68M--0--0--5.66M27,890.00%19.59K-80.74%18.97K-81.15%18.56K--333--0
Cash from discontinued financing activities
Financing cash flow -51.68%332K325.69%33.17M146,813.77%27.27M--0--5.21M981,461.43%687.09K-75.34%7.79M-81.15%18.56K--7.77M--0
Net cash flow
Beginning cash position 26.18%23.37M-37.62%18.52M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M238.89%29.69M-30.75%23.19M-45.76%19.42M314.96%23.42M
Current changes in cash -56.85%-11.39M143.41%4.85M493.73%18.4M-263.83%-6.18M97.40%-103.97K-15.92%-7.26M-153.37%-11.17M-22.83%-4.67M263.33%3.77M-113.27%-4M
End cash Position 6.38%11.97M26.18%23.37M26.18%23.37M-78.56%4.97M-42.58%11.15M-51.94%11.26M-37.62%18.52M-37.62%18.52M-30.75%23.19M-45.76%19.42M
Free cash flow -47.47%-11.73M-49.39%-28.32M-89.24%-8.88M-54.41%-6.18M-32.89%-5.32M-26.88%-7.95M-77.73%-18.96M-20.21%-4.69M-73.30%-4M-198.43%-4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg